MBX Biosciences(MBX)
CARMEL, INBiotechnology
Focus: MBX Biosciences is a public biotech company headquartered in Carmel, Indiana, specializing in hormone analogues for rare endocrine diseases. The company operates at a small to mid-cap scale with a focused pipeline in endocrinology and rare disease indications.
Profile data last refreshed 9h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Total Funding
$130M
Open Jobs
12-2 this month
Stable — net -2 jobs in 30d
2 added, 4 removed. Backfill posture.
Should You Work at MBX Biosciences?
AI assessmentBest suited for early-stage biotech veterans comfortable with clinical-stage risk and willing to help build a commercial infrastructure from scratch around a rare disease franchise.
Why Work Here
- Lead a focused pipeline in rare endocrine diseases with 8 active trials, including Phase 3 candidate Canvuparatide for hypoparathyroidism
- Join a publicly traded company with active commercial and manufacturing expansion (3 roles each), signaling market confidence and near-term launch readiness
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
MBX 2109
Renal ImpairmentClinical Trials (1)
NCT06496217Safety and Pharmacokinetics Study of MBX 2109 in Adult Subjects With Normal and Impaired Renal Function
Phase 1Help build intelligence for MBX Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.